ACTRN12608000555358终止不适用
A Rising-Single-Dose and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of SCH 900117 in Healthy Volunteers and in Subjects with Rheumatoid Arthritis
Schering-Plough0 个研究点目标入组 40 人开始时间: 2008年11月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Part 1-Healthy volunteers
- •Part 2-Rheumatoid Arthritis >6mths
- •- >=5 swollen & tender joints
排除标准
- •History of malignancy, Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C.
研究者
相似试验
已完成
不适用
Rising Single Dose Safety, Tolerability and Pharmacokinetic Study of SCH 900229 in Healthy Adult Subjects10009841Alzheimer's diseaseNL-OMON34885Schering-Plough40
招募中
1 期
Single-Dose and Multiple-Dose, Dose-Escalation Study with LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients with Mild Cognitive Impairment Due to Alzheimer's Disease and Mild to Moderate Alzheimer's DiseaseHealthy/Mild Cognitive Impairment due to Alzheimer's Disease/Mild-to-moderate Alzheimer's DiseaseJPRN-jRCT2080223114Eli Lilly Japan K.K.
已完成
1 期
A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3002813 in Patients with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT2080222069Eli Lilly Japan K.K.
进行中（未招募）
1 期
A Single- and Multiple-dose Study of Tedizolid Phosphate in Pediatric Subjects Aged <2 YearsEUCTR2017-000953-38-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.42
进行中（未招募）
1 期
A Single- and Multiple-dose Study of Tedizolid Phosphate in Pediatric Subjects Aged <2 YearsTreatment or prophylaxis against Gram-positive infectionsMedDRA version: 20.1Level: PTClassification code 10052891Term: Skin bacterial infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-000953-38-NOMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.42